A somatic mutation of RasGRP3 decreases Na<sup>+</sup>/I<sup>-</sup> symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway.

Jianlu Song, Wangwang Qiu, Xianzhao Deng, Zhongling Qiu, Youben Fan, Zhili Yang

PubMed · 2018 · 10 citations · 18 references

Full text

Open access

Concepts

Abstract

is a more frequent genetic alteration in metastases of RAI-refractory differentiated thyroid cancer. This mutant RasGRP3 activated the Akt pathway, promoted thyroid cancer cell proliferation and invasion, and reduced NIS expression and the iodine uptake ability.

References

18